ZIRCON and Beyond: CA9 Imaging, KIM-1, and Other Emerging Tools in RCC Diagnostics

2 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this conversation, Drs. Sam Chang and Dan Joyce, of Vanderbilt University Medical Center, explore the evolving role of CA9 imaging and the impact of the ZIRCON trial on managing small renal masses. They weigh in on how girentuximab can aid in identifying clear cell RCC and its potential to support decision-making in patients who may not be ideal biopsy candidates. The conversation also touches on how CA9 could help reduce patient anxiety in active surveillance scenarios and the future role of biomarkers like KIM-1 in guiding treatment.

#kidneycancer #renalcellcarcinoma #urology #onowaeberkah #cancerresearch
Category
Urology
Be the first to comment

Up Next